アレルギー治療市場：種類別、治療タイプ別、投与経路別、流通チャネル別-2025-2030年の世界予測

アレルギー治療市場は、2023年に291億5,000万米ドルと評価され、2024年には315億6,000万米ドルに達すると予測され、CAGR 8.65%で成長し、2030年には521億2,000万米ドルに達すると予測されています。

アレルギー治療市場には、抗ヒスタミン薬、コルチコステロイド、免疫療法などの医薬品に加え、呼吸器アレルギー、皮膚アレルギー、食物アレルギーに対応する高度な生物製剤や新規治療薬など、幅広い領域が含まれます。強固なアレルギー治療の必要性は、都市化、公害、ライフスタイルの変化による罹患率の上昇によって強調され、効果的な管理ソリューションへの需要を高めています。アレルギー治療の応用は、鼻づまり、皮膚の炎症、アナフィラキシーなどの症状を緩和し、入院を減らすことで生活の質を高めるために不可欠です。最終用途の範囲は診療所、病院、家庭など多岐にわたり、これらの治療オプションの柔軟性と利用しやすさが強調されています。市場成長は、意識の高まり、新興国におけるヘルスケア支出の増加、新規製品を生み出す継続的な調査によって大きな影響を受けています。個別化医療と生物製剤、特に標的治療戦略を提供するモノクローナル抗体には潜在的なビジネスチャンスが急増しています。リアルタイムのアレルギーモニタリング用ウェアラブルデバイスや遠隔医療サービスなどのデジタルヘルス技術革新も新たな道を開いています。市場の情勢には、高度な治療にかかる高額な費用、厳しい規制状況、成長を抑制する可能性のある医療アクセスの地域格差などの課題があります。革新のための最良の分野は、費用対効果が高く非侵襲的な代替品の開発、バイオテクノロジーを活用して有効性を高めること、AIと機械学習を統合して予測診断と個別化治療計画を実現することに重点が置かれます。市場はダイナミックで、急速な技術の進歩と消費者の嗜好の変化を特徴としており、持続的な成功のためには継続的な適応が必要です。企業は、新たな動向を活用し、満たされていないニーズに対応するために、研究開発パートナーシップや戦略的提携に投資すべきです。全体として、バイオテクノロジーとデジタルヘルスの統合における積極的なアプローチは、アクセシビリティと規制遵守に関する課題が効果的に管理されれば、大きな成長を引き出す可能性があります。

市場力学：急速に進化するアレルギー治療市場の主要市場インサイトを公開

アレルギー治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 国民の間でアレルギー疾患の有病率が上昇
  • OTCおよびオンライン薬局への嗜好の高まり
• 市場抑制要因
  • アレルギー治療に使用される原材料コストの変動
• 市場機会
  • 高度なアレルギー治療を導入するための活発な研究活動
  • 遠隔医療とバーチャル・ヘルスケア・サービスの登場
• 市場の課題
  • アレルギー治療の製造に関連する品質問題

ポーターのファイブフォース：アレルギー治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アレルギー治療市場における外部からの影響の把握

外部マクロ環境要因は、アレルギー治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：アレルギー治療市場における競合情勢の把握

アレルギー治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：アレルギー治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アレルギー治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：アレルギー治療市場における成功への道筋を描く

アレルギー治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口におけるアレルギー疾患の有病率の上昇
    • OTCおよびオンライン薬局への嗜好の高まり
  • 抑制要因
    • アレルギー治療に使用される原材料のコスト変動
  • 機会
    • 先進的なアレルギー治療の導入に向けた強力な調査活動
    • 遠隔医療とバーチャルヘルスケアサービスの出現
  • 課題
    • アレルギー薬の製造に伴う品質問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アレルギー治療市場：タイプ別

• 喘息
• 目のアレルギー
• 食物アレルギー
• 鼻炎
• 皮膚アレルギー

第7章 アレルギー治療市場治療の種類別

• 抗アレルギー薬
• 免疫療法

第8章 アレルギー治療市場：投与経路別

• 鼻腔
• オーラル
• 非経口

第9章 アレルギー治療市場：流通チャネル別

• オフライン
  • ドラッグストア
  • 小売薬局
• オンライン

第10章 南北アメリカのアレルギー治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のアレルギー治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのアレルギー治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ALK-Abello A/S
• Alladapt Immunotherapeutics, Inc.
• Allergopharma GmbH & Co. KG
• Allergy Therapeutics PLC
• Bayer AG
• Bristol-Myers Squibb Company
• ClostraBio, Inc.
• Connote Healthcare
• DBV Technologies
• GentiBio, Inc.
• GlaxoSmithKline PLC
• HollisterStier Allergy
• IgGenix, Inc.
• Indoor Biotechnologies, Inc.
• Inimmune
• Monark Biocare Private Limited
• OptiNose US, Inc.
• Reacta Healthcare
• Sanofi S.A.
• Stallergenes Greer International AG
• Taiho Pharmaceutical Co., Ltd.
• Third Harmonic Bio
• Trillium Health Care Products, Inc
• Upstream Bio, Inc.

LIST OF FIGURES

• FIGURE 1. ALLERGY TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. ALLERGY TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ALLERGY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ALLERGY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ALLERGY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ALLERGY TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ALLERGY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ALLERGY TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY EYE ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY SKIN ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. CHINA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. INDIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. ITALY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. POLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. QATAR ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 235. ALLERGY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. ALLERGY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Allergy Treatment Market was valued at USD 29.15 billion in 2023, expected to reach USD 31.56 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 52.12 billion by 2030.

The allergy treatment market encompasses a broad scope that includes pharmaceuticals such as antihistamines, corticosteroids, and immunotherapy, along with advanced biologics and novel therapeutics addressing respiratory, dermal, and food allergies. The necessity for robust allergy treatments is underscored by rising incidence rates fueled by urbanization, pollution, and lifestyle changes, increasing the demand for effective management solutions. Applications of allergy treatments are vital for enhancing quality of life by alleviating symptoms like congestion, skin irritation, and anaphylaxis, and reducing hospital admissions. End-use scope spans across clinics, hospitals, and home settings, highlighting the flexibility and accessibility of these treatment options. Market growth is significantly influenced by heightened awareness, increased healthcare spending in emerging economies, and ongoing research yielding novel products. There's a surge in potential opportunities within personalized medicine and biologics, particularly monoclonal antibodies offering targeted treatment strategies-segments poised for expansion as consumers seek tailored therapeutics. Digital health innovations such as wearable devices for real-time allergy monitoring and telehealth services are also opening new pathways. Challenges in the market include high costs of advanced treatments, stringent regulatory landscapes, and regional disparities in healthcare access that could restrain growth. Best areas for innovation focus on developing cost-effective, non-invasive alternatives, leveraging biotechnology to enhance efficacy, and integrating AI and machine learning for predictive diagnostics and personalized treatment plans. The market is dynamic, characterized by rapid technological advancements and shifting consumer preferences, which necessitate continual adaptation for sustained success. Companies should invest in R&D partnerships and strategic collaborations to leverage emerging trends and address unmet needs. Overall, proactive approaches in biotechnology and digital health integration could unlock significant growth, provided challenges related to accessibility and regulatory compliance are effectively managed.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Treatment Market

The Allergy Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of allergic conditions among population
  • Growing preferences toward OTC and online pharmacy
• Market Restraints
  • Fluctuating cost of raw materials used in allergy medications
• Market Opportunities
  • Robust research activities to introduce advanced allergic treatments
  • Emergence of telemedicine and virtual healthcare services
• Market Challenges
  • Quality issues associated with production of allergy medicines

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Treatment Market

A detailed market share analysis in the Allergy Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Treatment Market

A strategic analysis of the Allergy Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Treatment Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Alladapt Immunotherapeutics, Inc., Allergopharma GmbH & Co. KG, Allergy Therapeutics PLC, Bayer AG, Bristol-Myers Squibb Company, ClostraBio, Inc., Connote Healthcare, DBV Technologies, GentiBio, Inc., GlaxoSmithKline PLC, HollisterStier Allergy, IgGenix, Inc., Indoor Biotechnologies, Inc., Inimmune, Monark Biocare Private Limited, OptiNose US, Inc., Reacta Healthcare, Sanofi S.A., Stallergenes Greer International AG, Taiho Pharmaceutical Co., Ltd., Third Harmonic Bio, Trillium Health Care Products, Inc, and Upstream Bio, Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Asthma, Eye Allergy, Food Allergy, Rhinitis, and Skin Allergy.
• Based on Treatment Type, market is studied across Anti-Allergy Drugs and Immunotherapy.
• Based on Route of Administration, market is studied across Nasal, Oral, and Parenteral.
• Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Drug Stores and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of allergic conditions among population
    • 5.1.1.2. Growing preferences toward OTC and online pharmacy
  • 5.1.2. Restraints
    • 5.1.2.1. Fluctuating cost of raw materials used in allergy medications
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust research activities to introduce advanced allergic treatments
    • 5.1.3.2. Emergence of telemedicine and virtual healthcare services
  • 5.1.4. Challenges
    • 5.1.4.1. Quality issues associated with production of allergy medicines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Allergy Treatment Market, by Type

• 6.1. Introduction
• 6.2. Asthma
• 6.3. Eye Allergy
• 6.4. Food Allergy
• 6.5. Rhinitis
• 6.6. Skin Allergy

7. Allergy Treatment Market, by Treatment Type

• 7.1. Introduction
• 7.2. Anti-Allergy Drugs
• 7.3. Immunotherapy

8. Allergy Treatment Market, by Route of Administration

• 8.1. Introduction
• 8.2. Nasal
• 8.3. Oral
• 8.4. Parenteral

9. Allergy Treatment Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline
  • 9.2.1. Drug Stores
  • 9.2.2. Retail Pharmacies
• 9.3. Online

10. Americas Allergy Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Allergy Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ALK-Abello A/S
• 2. Alladapt Immunotherapeutics, Inc.
• 3. Allergopharma GmbH & Co. KG
• 4. Allergy Therapeutics PLC
• 5. Bayer AG
• 6. Bristol-Myers Squibb Company
• 7. ClostraBio, Inc.
• 8. Connote Healthcare
• 9. DBV Technologies
• 10. GentiBio, Inc.
• 11. GlaxoSmithKline PLC
• 12. HollisterStier Allergy
• 13. IgGenix, Inc.
• 14. Indoor Biotechnologies, Inc.
• 15. Inimmune
• 16. Monark Biocare Private Limited
• 17. OptiNose US, Inc.
• 18. Reacta Healthcare
• 19. Sanofi S.A.
• 20. Stallergenes Greer International AG
• 21. Taiho Pharmaceutical Co., Ltd.
• 22. Third Harmonic Bio
• 23. Trillium Health Care Products, Inc
• 24. Upstream Bio, Inc.